Show simple item record

dc.contributor.authorViñolo Gil, María Jesús 
dc.contributor.authorGarcía Campanario, Ismael 
dc.contributor.authorEstebanez-Pérez, María José
dc.contributor.authorPastora-Bernal, José Manuel
dc.contributor.authorRodríguez Huguet, Manuel 
dc.contributor.authorMartín Vega, Francisco Javier 
dc.contributor.otherEnfermería y Fisioterapiaes_ES
dc.contributor.otherMedicinaes_ES
dc.date.accessioned2024-06-14T13:21:53Z
dc.date.available2024-06-14T13:21:53Z
dc.date.issued2023
dc.identifier.issn2227-9032
dc.identifier.urihttp://hdl.handle.net/10498/32576
dc.description.abstractBackground: Cancer, being a highly widespread disease on a global scale, has prompted researchers to explore innovative treatment approaches. In this regard, blood flow restriction has emerged as a promising procedure utilized in diverse clinical populations with favorable results including improvements in muscle strength, cardiovascular function, and postoperative recovery. The aim of this systematic review was to assess the efficacy of blood flow restriction in cancer survivors. Methods: An investigation was carried out using various databases until February 2023: PubMed, Scientific Electronic Library Online, Physiotherapy Evidence Database, Scopus, Web of Science, Cochrane Plus, SPORTDiscus, Physiotherapy and Podiatry of the Complutense University of Madrid, ScienceDirect, ProQuest, Research Library, Cumulative Index of Nursing and Allied Literature Complete Journal Storage, and the gray literature. To assess the methodological quality of the studies, the PEDro scale was utilized, and the Cochrane Collaboration tool was employed to evaluate the risk of bias. Results: Five articles found that blood flow restriction was beneficial in improving several factors, including quality of life, physical function, strength, and lean mass, and in reducing postoperative complications and the length of hospital stay. Conclusion: Blood flow restriction can be a viable and effective treatment option. It is important to note that the caution with which one should interpret these results is due to the restricted quantity of articles and significant variation, and future research should concentrate on tailoring the application to individual patients, optimizing load progression, ensuring long-term follow-up, and enhancing the methodological rigor of studies, such as implementing sample blinding.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceHealthcare (Switzerland), Vol. 11, Núm. 14, 2023es_ES
dc.subjectblood flow restrictiones_ES
dc.subjectblood flow restriction exercisees_ES
dc.subjectblood occlusiones_ES
dc.subjectcanceres_ES
dc.subjectcancer survivorses_ES
dc.subjectKAATSU traininges_ES
dc.subjectneoplasmses_ES
dc.subjectoncologyes_ES
dc.titleBlood Flow Restriction in Oncological Patients: Advantages and Safety Considerationses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.3390/HEALTHCARE11142062
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional